Sabaa Pharmaceutical's shareholders approve capital raise via bonus issue
Sabaa Pharmaceutical's profit leaps 76% in 2020 initial results
WHO ‘strongly’ against hydroxychloroquine use for COVID-19 prevention
© 2021 - 2025 All Rights Reserved. Designed & Developed By Spark Systems
